Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Careen Y. Lowder, MD, PhD, was born in Hong Kong, SAR China, and raised in Brazil where she completed her secondary education. She obtained her BA, MD and PhD degrees at Case Western Reserve University in Cleveland, Ohio. She completed her internship and residency in ophthalmology at Cleveland Clinic. This was followed by fellowships in uveitis at F.I. Proctor Foundation and in ophthalmic pathology, both at the University of California San Francisco.
Dr. Lowder has been a full, professional Staff Physician at Cleveland Clinic since 1986. She is Past-President of the Cleveland Ophthalmological Society and was on its Education Committee from 1994 through 2004. Dr. Lowder has been Activity Director for Ophthalmology Grand Rounds since 1999 and a member of the Board of Directors of the Cleveland Clinic Alumni Association as Specialty Director for Ophthalmology from 2002-2010. She was elected President of the Panamerican Society in Ocular Inflammatory Diseases in 1999.
Dr. Lowder has been leader of the World Class Service Team at Cleveland Clinic Cole Eye Institute, and patient satisfaction has improved from 42% excellent to 84% during her tenure. Dr. Lowder is frequently invited to speak at national and international meetings and has more than 100 publications in the field of uveitis.
cataract and lens implant surgery, Ocular Inflammatory Diseases, Pathology, Uveitis
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 10/27/2014, Dr. Lowder has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Charity. Dr. Lowder has consulted for the following companies but instructed them to donate all compensation directly to one or more non-profit organizations:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.